Annexon (ANNX) News Today $6.12 -0.21 (-3.32%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Annexon, Inc. (NASDAQ:ANNX) Short Interest Down 12.9% in OctoberAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 7,770,000 shares, a decline of 12.9% from the October 15th total of 8,920,000 shares. Based on an average daily trading volume, of 1,270,000 shares, the days-to-cover ratio is presently 6.1 days.November 16 at 7:32 AM | marketbeat.comAnnexon Biosciences’ Promising Future: Buy Rating Backed by Strategic Decisions and Financial StabilityNovember 15 at 5:33 PM | markets.businessinsider.comAnnexon Biosciences: Promising Phase 3 Results and Pipeline Potential Justify Buy RatingNovember 15 at 5:33 PM | markets.businessinsider.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)November 15 at 4:59 PM | globenewswire.comAnnexon's (ANNX) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of Annexon in a research report on Friday.November 15 at 10:33 AM | marketbeat.comAnnexon (NASDAQ:ANNX) Given "Buy" Rating at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $16.00 price target on shares of Annexon in a research note on Friday.November 15 at 8:50 AM | marketbeat.comAnnexon's (ANNX) Buy Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $30.00 price objective on shares of Annexon in a report on Friday.November 15 at 8:30 AM | marketbeat.comAnnexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated MilestonesNovember 14 at 8:00 AM | globenewswire.comAnnexon Biosciences to Present at the Jefferies London Healthcare ConferenceNovember 13, 2024 | globenewswire.comAnnexon, Inc. (NASDAQ:ANNX) Receives $15.80 Average Target Price from AnalystsNovember 11, 2024 | americanbankingnews.comAnnexon, Inc. (NASDAQ:ANNX) Receives Average Recommendation of "Buy" from BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have received an average recommendation of "Buy" from the six research firms that are currently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price objective amoNovember 8, 2024 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)October 24, 2024 | markets.businessinsider.comAnnexon Reports Promising Phase 2 Data For ANX007 In Geographic Atrophy Due To Dry AMDOctober 22, 2024 | markets.businessinsider.comAnnexon presents Phase 2 Vision Preservation data with ANX007 in dry AMDOctober 22, 2024 | msn.comWe're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash WiselyOctober 21, 2024 | finance.yahoo.comAnnexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 MeetingOctober 21, 2024 | globenewswire.comInsider Selling: Annexon, Inc. (NASDAQ:ANNX) EVP Sells 5,408 Shares of StockOctober 18, 2024 | insidertrades.comAnnexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 MeetingOctober 15, 2024 | finance.yahoo.comAnnexon, Inc. (NASDAQ:ANNX) Receives Consensus Rating of "Buy" from BrokeragesAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) has earned an average rating of "Buy" from the six analysts that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have updatOctober 14, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Holdings Raised by AQR Capital Management LLCAQR Capital Management LLC lifted its position in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 2,356.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 279,463 shares of the company's stock after purcOctober 11, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Stake Raised by Dimensional Fund Advisors LPDimensional Fund Advisors LP raised its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 146.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 822,605 shares of theOctober 10, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading 4.7% Higher - Time to Buy?Annexon (NASDAQ:ANNX) Trading Up 4.7% - Should You Buy?October 8, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comAnnexon director Carson buys $19k in company stockOctober 4, 2024 | investing.comSusquehanna Fundamental Investments LLC Purchases 129,455 Shares of Annexon, Inc. (NASDAQ:ANNX)Susquehanna Fundamental Investments LLC lifted its position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 385.6% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 163,025 shares of the company's stock after pOctober 3, 2024 | marketbeat.comDirector William Carson Acquires 3,200 Shares of Annexon Inc (ANNX)October 3, 2024 | gurufocus.comAnnexon (NASDAQ:ANNX) Shares Up 6.5%Annexon (NASDAQ:ANNX) Trading Up 6.5%October 2, 2024 | marketbeat.comBuy Rating Affirmed for Annexon Biosciences Amidst Promising Clinical Developments and Market PotentialOctober 1, 2024 | markets.businessinsider.comRenaissance Technologies LLC Lowers Position in Annexon, Inc. (NASDAQ:ANNX)Renaissance Technologies LLC trimmed its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 13.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 584,200 shares of the company's stock after selling 87,000 shares during the quarter. RenaiOctober 1, 2024 | marketbeat.comSusquehanna Portfolio Strategies LLC Decreases Stake in Annexon, Inc. (NASDAQ:ANNX)Susquehanna Portfolio Strategies LLC lessened its stake in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 73.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 37,660 shares of the company's stock after selling 103,902 shares dSeptember 30, 2024 | marketbeat.comPoint72 Asset Management L.P. Purchases 832,617 Shares of Annexon, Inc. (NASDAQ:ANNX)Point72 Asset Management L.P. raised its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 16.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,989,017 shares of the company's stock after buying an additional 83September 27, 2024 | marketbeat.com234,592 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by Point72 Europe London LLPPoint72 Europe London LLP acquired a new position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 234,592 shares of the company's stock, valued at apSeptember 26, 2024 | marketbeat.comMutual of America Capital Management LLC Buys New Stake in Annexon, Inc. (NASDAQ:ANNX)Mutual of America Capital Management LLC bought a new stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 639,573 shares of the company's stock, valued at approximately $3,134September 24, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 5.3% Following Insider SellingAnnexon (NASDAQ:ANNX) Stock Price Down 5.3% on Insider SellingSeptember 23, 2024 | marketbeat.comANNX Jan 2025 4.000 putSeptember 22, 2024 | ca.finance.yahoo.comMassachusetts Financial Services Co. MA Increases Holdings in Annexon, Inc. (NASDAQ:ANNX)Massachusetts Financial Services Co. MA lifted its position in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 37.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,064,801 shares of the company's stock aSeptember 22, 2024 | marketbeat.comANNX Oct 2024 4.000 callSeptember 21, 2024 | ca.finance.yahoo.comANNX Jan 2025 10.000 callSeptember 21, 2024 | ca.finance.yahoo.comInsider Selling: Annexon, Inc. (NASDAQ:ANNX) EVP Sells 4,500 Shares of StockSeptember 21, 2024 | insidertrades.comAnnexon, Inc. (NASDAQ:ANNX) EVP Sells $31,950.00 in StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) EVP Ted Yednock sold 4,500 shares of the stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $7.10, for a total transaction of $31,950.00. Following the sale, the executive vice president now owns 71,365 shares in the company, valued at approximately $506,691.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.September 20, 2024 | marketbeat.comBank of New York Mellon Corp Boosts Stock Position in Annexon, Inc. (NASDAQ:ANNX)Bank of New York Mellon Corp boosted its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 42.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 258,033 shares of theSeptember 20, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 2.7%Annexon (NASDAQ:ANNX) Shares Down 2.7%September 17, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading 6.8% Higher Annexon (NASDAQ:ANNX) Shares Up 6.8%September 9, 2024 | marketbeat.comArbutus Biopharma Corporation (I9DN.F)September 9, 2024 | sg.finance.yahoo.comCandriam S.C.A. Buys Shares of 2,053,459 Annexon, Inc. (NASDAQ:ANNX)Candriam S.C.A. bought a new stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,053,459 shares of the company's stock, valued at approximately $10,061,000. Candriam S.C.A.September 9, 2024 | marketbeat.comTed Yednock Sells 5,500 Shares of Annexon, Inc. (NASDAQ:ANNX) StockSeptember 8, 2024 | insidertrades.comAnnexon, Inc. (NASDAQ:ANNX) EVP Sells 5,500 SharesSeptember 7, 2024 | insidertrades.comInsider Selling: Annexon, Inc. (NASDAQ:ANNX) EVP Sells 5,500 Shares of StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) EVP Ted Yednock sold 5,500 shares of Annexon stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $5.64, for a total value of $31,020.00. Following the completion of the transaction, the executive vice president now owns 10,000 shares in the company, valued at approximately $56,400. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.September 6, 2024 | marketbeat.com200,000 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by Ovata Capital Management LtdOvata Capital Management Ltd bought a new position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 200,000 shares of the company's stock, valued at approximately $980,000. Annexon accounts for approSeptember 6, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Director Buys $17,536.00 in StockSeptember 5, 2024 | insidertrades.com Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide ANNX Media Mentions By Week ANNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANNX News Sentiment▼0.500.56▲Average Medical News Sentiment ANNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANNX Articles This Week▼153▲ANNX Articles Average Week Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PLRX News Today TBPH News Today ENTA News Today SNDX News Today JANX News Today VCEL News Today CPRX News Today GMTX News Today IOVA News Today IDYA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANNX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
